Ho visitato oggi l'azienda Catalent di... - Roberto Speranza | Facebook
J&J plant authorization clears way for big boost in U.S. COVID-19 shots | Reuters
Azioni USA: Johnson & Johnson pattern rialzista, Catalent in rialzo del 54% nel 2023 - fxempire.it
Catalent Biologics Manufacturing Facility Expansion, Anagni, Italy
Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed | CNN
Catalent to Expand Production of J&J Covid-19 Vaccine in Italy - WSJ
Catalent Distributing Johnson & Johnson Vaccine | news - Indiana Public Media
Catalent Signs Agreement with Johnson & Johnson for COVID-19 Vaccine Candidate
J&J Partner Catalent Gets Key U.S. Approval to Make Vaccine - Bloomberg
Catalent breaks ground at US$112m drug product manufacturing facility
Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed | CNN
Covid-19 : Catalent va produire pour Johnson & Johnson
Catalent rinforza la partnership con Moderna – Daily Health Industry
FDA authorizes J&J partner to help with vaccine production - POLITICO
Addio Catalent a Anagni, "burocrazia troppo lunga ci spostiamo in Gb". Persi 100 posti di lavoro - la Repubblica
White House knew more than a week ago of J&J contractor vaccine-supply problems - POLITICO
Coronavirus: Catalent va accélérer la production de vaccins de Johnson & Johnson - Challenges
Catalent to ramp up J&J vaccine production at Italian plant | Reuters
Why There Will Be Fewer Johnson & Johnson COVID-19 Vaccines Next Week : NPR
Accelerating Development & Manufacturing of Biologics
Catalent plans to expand production of J&J COVID-19 vaccine in Italy - WSJ | Reuters
J&J cuts production of underperforming COVID vaccine: WSJ
Vaccini prodotti a Anagni: la società Catalent rinuncia e trasloca in Inghilterra- Corriere.it
Anagni, in fumo il progetto da 100 milioni di Catalent per la produzione di vaccini - AboutPharma
Catalent Expands Partnership with Johnson & Johnson for COVID-19 Vaccine
